Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 28 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 9908841

    Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted

  2. US 9902734

    Nicotinic acetylcholine receptor agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted

  3. US 9896509

    Use of antagonists of the interaction between HIV GP120 and α4β7 integrin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  4. US 9889115

    Fitness assay and associated methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  5. US 9890369

    Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin lethal factor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  6. US 9884104

    Live attenuated virus vaccines for la crosse virus and other bunyaviridae

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  7. US 9879231

    Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  8. US 9879065

    T cell receptors recognizing MHC class II-restricted MAGE-A3

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  9. US 9873702

    Heterocyclic compounds as biogenic amine transport modulators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted

  10. US 9868954

    Reduction of TGFβ signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  11. US 9868774

    Anti-CD22 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  12. US 9867830

    Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  13. US 9862679

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  14. US 9856313

    Epitope of RSV fusion protein and antibody recognizing the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  15. US 9855298

    Methods of conditioning patients for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  16. US 9855330

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  17. US 9856453

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  18. US 9850468

    Infectious hepatitis E virus genotype 3 recombinants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

  19. US 9845350

    Monoclonal antibodies that react with the capsule of bacillus anthracis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  20. US 9833519

    Methods for the diagnosis and treatment of sjögren's syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  21. US 9827223

    Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted

  22. US 9820965

    Biologically active macrolides, compositions, and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  23. US 9822162

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  24. US 9815887

    Monoclonal antibodies that neutralize a norovirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.